PTKFF
Price
$0.10
Change
+$0.01 (+11.11%)
Updated
Aug 1 closing price
Capitalization
3.53B
RCDTF
Price
$65.44
Change
+$9.40 (+16.77%)
Updated
Jun 13 closing price
Capitalization
12.64B
Interact to see
Advertisement

PTKFF vs RCDTF

Header iconPTKFF vs RCDTF Comparison
Open Charts PTKFF vs RCDTFBanner chart's image
PT Kalba Farma TBK
Price$0.10
Change+$0.01 (+11.11%)
Volume$53K
Capitalization3.53B
Recordati Industria Chimica e Farmaceutica S.p.A
Price$65.44
Change+$9.40 (+16.77%)
Volume$300
Capitalization12.64B
PTKFF vs RCDTF Comparison Chart in %
Loading...
PTKFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PTKFF vs. RCDTF commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PTKFF is a Buy and RCDTF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (PTKFF: $0.10 vs. RCDTF: $65.44)
Brand notoriety: PTKFF and RCDTF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: PTKFF: 227% vs. RCDTF: 100%
Market capitalization -- PTKFF: $3.53B vs. RCDTF: $12.64B
PTKFF [@Pharmaceuticals: Major] is valued at $3.53B. RCDTF’s [@Pharmaceuticals: Major] market capitalization is $12.64B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $656.17B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $88.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PTKFF’s FA Score shows that 1 FA rating(s) are green whileRCDTF’s FA Score has 1 green FA rating(s).

  • PTKFF’s FA Score: 1 green, 4 red.
  • RCDTF’s FA Score: 1 green, 4 red.
According to our system of comparison, both PTKFF and RCDTF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PTKFF’s TA Score shows that 3 TA indicator(s) are bullish.

  • PTKFF’s TA Score: 3 bullish, 0 bearish.

Price Growth

PTKFF (@Pharmaceuticals: Major) experienced а 0.00% price change this week, while RCDTF (@Pharmaceuticals: Major) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.92%. For the same industry, the average monthly price growth was +1.19%, and the average quarterly price growth was +11.79%.

Industries' Descriptions

@Pharmaceuticals: Major (-1.92% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCDTF($12.6B) has a higher market cap than PTKFF($3.53B). RCDTF has higher P/E ratio than PTKFF: RCDTF (28.88) vs PTKFF (20.96). RCDTF YTD gains are higher at: 17.825 vs. PTKFF (0.789). PTKFF has higher annual earnings (EBITDA): 4.87T vs. RCDTF (819M). PTKFF has more cash in the bank: 3.95T vs. RCDTF (342M). RCDTF has less debt than PTKFF: RCDTF (2.47B) vs PTKFF (780B). PTKFF has higher revenues than RCDTF: PTKFF (33.38T) vs RCDTF (2.48B).
PTKFFRCDTFPTKFF / RCDTF
Capitalization3.53B12.6B28%
EBITDA4.87T819M594,261%
Gain YTD0.78917.8254%
P/E Ratio20.9628.8873%
Revenue33.38T2.48B1,345,927%
Total Cash3.95T342M1,155,263%
Total Debt780B2.47B31,553%
FUNDAMENTALS RATINGS
PTKFF vs RCDTF: Fundamental Ratings
PTKFF
RCDTF
OUTLOOK RATING
1..100
4648
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
22
Undervalued
PROFIT vs RISK RATING
1..100
9373
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4747
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
7555

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PTKFF's Valuation (21) in the null industry is in the same range as RCDTF (22). This means that PTKFF’s stock grew similarly to RCDTF’s over the last 12 months.

RCDTF's Profit vs Risk Rating (73) in the null industry is in the same range as PTKFF (93). This means that RCDTF’s stock grew similarly to PTKFF’s over the last 12 months.

RCDTF's SMR Rating (100) in the null industry is in the same range as PTKFF (100). This means that RCDTF’s stock grew similarly to PTKFF’s over the last 12 months.

RCDTF's Price Growth Rating (47) in the null industry is in the same range as PTKFF (47). This means that RCDTF’s stock grew similarly to PTKFF’s over the last 12 months.

RCDTF's P/E Growth Rating (100) in the null industry is in the same range as PTKFF (100). This means that RCDTF’s stock grew similarly to PTKFF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PTKFFRCDTF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
55%
N/A
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
38%
Bullish Trend 1 day ago
19%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
42%
Bullish Trend 1 day ago
18%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
49%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
PTKFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OARDX27.27N/A
N/A
Invesco Rising Dividends A
ISMOX4.43N/A
N/A
Voya MidCap Opportunities Port S
OIEQX26.10N/A
N/A
JPMorgan Equity Income R4
RSGRX34.33N/A
N/A
Victory RS Growth A
MRESX11.55-0.03
-0.26%
Cromwell CenterSquare Real Estate Inv

PTKFF and

Correlation & Price change

A.I.dvisor tells us that PTKFF and SNPHF have been poorly correlated (+2% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PTKFF and SNPHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTKFF
1D Price
Change %
PTKFF100%
N/A
SNPHF - PTKFF
2%
Poorly correlated
N/A
OTSKY - PTKFF
1%
Poorly correlated
+0.38%
OTSKF - PTKFF
0%
Poorly correlated
N/A
RCDTF - PTKFF
0%
Poorly correlated
N/A
SNPHY - PTKFF
-0%
Poorly correlated
+3.82%
More

RCDTF and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCDTF has been loosely correlated with VRBCF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if RCDTF jumps, then VRBCF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCDTF
1D Price
Change %
RCDTF100%
N/A
VRBCF - RCDTF
56%
Loosely correlated
N/A
RHHBF - RCDTF
3%
Poorly correlated
-3.04%
RHHBY - RCDTF
2%
Poorly correlated
-0.07%
PTKFY - RCDTF
0%
Poorly correlated
-0.94%
PTKFF - RCDTF
0%
Poorly correlated
N/A
More